Current insights into breast and ovarian cancer risk: a contemporary review.

IF 0.8 4区 医学 Q2 SURGERY
Natalie A Gaughan, Nicole Rademacher, Christine Rogers, Anna Purdy, Joanne D Mattingly, Caitlin R Patten, Adrienne N Cobb, Amanda L Kong, Chandler S Cortina
{"title":"Current insights into breast and ovarian cancer risk: a contemporary review.","authors":"Natalie A Gaughan, Nicole Rademacher, Christine Rogers, Anna Purdy, Joanne D Mattingly, Caitlin R Patten, Adrienne N Cobb, Amanda L Kong, Chandler S Cortina","doi":"10.23736/S2724-5691.25.10651-5","DOIUrl":null,"url":null,"abstract":"<p><p>Breast and ovarian cancer account for millions of new cancer diagnoses worldwide annually. An individual's risk of breast and/or ovarian cancer is the result of a complex interplay between non-modifiable and modifiable factors. This review provides a comprehensive map of the current state of our understanding of breast and ovarian cancer risk as conducted through a literature review utilizing PubMed and Cochrane review as primary databases and the selection process prioritized year of publication for up-to-date research and journal impact factor as criteria of research credibility. We review non-modifiable risk factors, such as genetic variations, age, sex assigned at birth, and reproductive history as well as how advances in genetic mapping have led to increased insight in pathogenic germline variants. Additionally, we discuss modifiable factors such as lifestyle and environmental exposures which allow the opportunity for intervention to reduce risk. Contemporary high risk screening tools, including understanding their strengths and weaknesses, are discussed and how they can lend to the determination of eligibility for preventive measures, including risk-reducing operations. The unique challenges of under-represented groups, such as non-Hispanic Black women, transgender/nonbinary/and gender-diverse individuals, and Asian and Pacific Islander populations are reviewed in the context of breast and ovarian cancer risk. Future research on improving risk assessment tools and identifying genomic variants will yield improved personalized healthcare solutions.</p>","PeriodicalId":29847,"journal":{"name":"Minerva Surgery","volume":"80 4","pages":"334-353"},"PeriodicalIF":0.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.23736/S2724-5691.25.10651-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Breast and ovarian cancer account for millions of new cancer diagnoses worldwide annually. An individual's risk of breast and/or ovarian cancer is the result of a complex interplay between non-modifiable and modifiable factors. This review provides a comprehensive map of the current state of our understanding of breast and ovarian cancer risk as conducted through a literature review utilizing PubMed and Cochrane review as primary databases and the selection process prioritized year of publication for up-to-date research and journal impact factor as criteria of research credibility. We review non-modifiable risk factors, such as genetic variations, age, sex assigned at birth, and reproductive history as well as how advances in genetic mapping have led to increased insight in pathogenic germline variants. Additionally, we discuss modifiable factors such as lifestyle and environmental exposures which allow the opportunity for intervention to reduce risk. Contemporary high risk screening tools, including understanding their strengths and weaknesses, are discussed and how they can lend to the determination of eligibility for preventive measures, including risk-reducing operations. The unique challenges of under-represented groups, such as non-Hispanic Black women, transgender/nonbinary/and gender-diverse individuals, and Asian and Pacific Islander populations are reviewed in the context of breast and ovarian cancer risk. Future research on improving risk assessment tools and identifying genomic variants will yield improved personalized healthcare solutions.

当前对乳腺癌和卵巢癌风险的认识:一项当代综述。
乳腺癌和卵巢癌每年在全球范围内造成数百万例新的癌症诊断。个体患乳腺癌和/或卵巢癌的风险是不可改变因素和可改变因素复杂相互作用的结果。本综述通过文献综述,利用PubMed和Cochrane综述作为主要数据库,选择最新研究的优先出版年份和期刊影响因子作为研究可信度的标准,提供了我们对乳腺癌和卵巢癌风险理解现状的全面地图。我们回顾了不可改变的风险因素,如遗传变异、年龄、出生时性别、生殖史,以及遗传作图的进展如何导致对致病种系变异的深入了解。此外,我们还讨论了可改变的因素,如生活方式和环境暴露,这些因素使干预有机会降低风险。讨论了当代高风险筛查工具,包括了解其优缺点,以及它们如何有助于确定采取预防措施的资格,包括降低风险的操作。在乳腺癌和卵巢癌风险的背景下,对代表性不足的群体,如非西班牙裔黑人妇女、跨性别/非二元/性别多样化个体、亚洲和太平洋岛民群体的独特挑战进行了审查。未来对改进风险评估工具和识别基因组变异的研究将产生改进的个性化医疗保健解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Minerva Surgery
Minerva Surgery SURGERY-
CiteScore
1.90
自引率
7.10%
发文量
320
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信